Ingredion Q2 Earnings: Adjusted EPS of $2.82 as Tate & Lyle Shareholders Greenlight $3.6B Acquisition
INGR is trading near its 52-week low of $94.44 (6.2% above the low).
Summary
Ingredion posted Q2 adjusted EPS of $2.82, slightly below the prior-year's $2.87, and reaffirmed its full-year outlook. The $3.6 billion all-cash acquisition of Tate & Lyle moved closer to completion after shareholder approval.
Key Events · Earnings and Guidance · INGR
-
Q2 Adjusted EPS $2.82, Guidance Reaffirmed
Adjusted EPS reached $2.82, compared with $2.87 in Q2 2025, while full-year adjusted EPS guidance was held at $10.30–$10.90. Reported operating income dropped 31% to $188M, weighed down by impairment, restructuring, and Argo thermal event charges.
-
Tate & Lyle Shareholders Approve $3.6B Deal
A critical milestone was reached on July 28 when Tate & Lyle shareholders accepted Ingredion's 595 pence all-cash offer, clearing the way for a combination that will create a global ingredient solutions leader.
-
$47M Non-Cash FX Loss Hits Financing Costs
Net financing costs ballooned to $55M from $12M, driven by a $47M mark-to-market loss on derivatives hedging GBP exposure for the Tate & Lyle acquisition—a non-cash item that will reverse.
-
Pakistan Stake Sale Completed for $165M
The divestiture of a 51% stake in Rafhan Maize closed, generating $165M in cash and a $44M pre-tax gain. The sale removes second-half earnings from Pakistan, which is reflected in updated guidance.
Analysis · INGR · Manufacturing
While Ingredion's Q2 reported operating income tumbled 31%, the adjusted decline was a modest 5%, revealing that one-time items—impairments, restructuring, and the Argo thermal event—are obscuring underlying resilience. Adjusted EPS came in at $2.82, nearly matching last year's $2.87, and full-year guidance was reaffirmed. The pivotal development, however, is the pending $3.6 billion Tate & Lyle acquisition: shareholder approval on July 28 removes a major obstacle. A $47 million mark-to-market FX loss on GBP hedges for the deal inflated financing costs, but this non-cash charge will reverse. The $165 million sale of the Pakistan stake provides some liquidity, yet substantial debt remains to fund the acquisition. With Argo back to normal and Texture & Healthful Solutions delivering its ninth straight quarter of volume growth, operations are strengthening, but integration risk and leverage continue to dominate the narrative.
At the time of this filing, INGR was trading at $100.34 on NYSE in the Manufacturing sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $94.44 to $130.67. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.